Patent details
EP1040094
Title:
SUBSTITUTED CYCLOPENTANE AND CYCLOPENTENE COMPOUNDS USEFUL AS NEURAMINIDASE INHIBITORS
Basic Information
- Publication number:
- EP1040094
- PCT Application Number:
- PCT/US/1998/026871
- Type:
- European Patent Granted for LU
- Legal Status:
- Expired
- Application number:
- EP989660030
- PCT Publication Number:
- WO/1999/033781
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- SUBSTITUTED CYCLOPENTANE AND CYCLOPENTENE COMPOUNDS USEFUL AS NEURAMINIDASE INHIBITORS
- French Title of Invention:
- COMPOSES DES CYCLOPENTANE ET CYCLOPENTENE CONVENANT COMME INHIBITEURS DE NEURAMINIDASE
- German Title of Invention:
- SUBSTITUIERTE CYCLOPENTAN- UND CYCLOPENTEN-VERBINDUNGEN ALS NEURAMINIDASE-BLOCKER
- SPC Number:
-
LUC00084
Dates
- Filing date:
- 17/12/1998
- Grant date:
- 18/03/2009
- EP Publication Date:
- 18/03/2009
- PCT Publication Date:
- 08/07/1999
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 04/10/2000
- EP B1 Publication Date:
- 18/03/2009
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 17/12/2018
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 22/08/2018
-
-
- Name:
- BIOCRYST PHARMACEUTICALS, INC.
- Address:
- 4505 Emperor Boulevard, Suite 200, Durham, North Carolina 27703, United States (US)
Inventor
1
- Name:
- BABU Yarlagadda, S.
- Address:
- United States (US)
2
- Name:
- MONTGOMERY John, A.
- Address:
- United States (US)
3
- Name:
- CHAND Pooran
- Address:
- United States (US)
Priority
1
- Priority Number:
- 69956 P
- Priority Date:
- 17/12/1997
- Priority Country:
- United States (US)
2
- Priority Number:
- 85252 P
- Priority Date:
- 13/05/1998
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
-
C07C 69/74;
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 28/11/2017
- Last Annual Fee Paid Number:
- 20
- Last Annual Fee Paid Amount:
- 300 Euro
- Payer:
- MARKS & CLERK LLP